Renaissance Technologies’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Sell |
396,200
-118,900
| -23% | -$762K | ﹤0.01% | 1966 |
|
|
2025
Q1 | $1.82M | Buy |
515,100
+50,700
| +11% | +$179K | ﹤0.01% | 2065 |
|
|
2024
Q4 | $1.76M | Buy |
464,400
+192,600
| +71% | +$728K | ﹤0.01% | 2140 |
|
|
2024
Q3 | $881K | Sell |
271,800
-539,688
| -67% | -$1.75M | ﹤0.01% | 2525 |
|
|
2024
Q2 | $1.54M | Buy |
811,488
+106,888
| +15% | +$203K | ﹤0.01% | 2044 |
|
|
2024
Q1 | $2M | Buy |
704,600
+633,312
| +888% | +$1.8M | ﹤0.01% | 2031 |
|
|
2023
Q4 | $1.05M | Sell |
71,288
-78,812
| -53% | -$1.16M | ﹤0.01% | 2371 |
|
|
2023
Q3 | $2.75M | Buy |
+150,100
| New | +$2.75M | ﹤0.01% | 1676 |
|
|
2023
Q1 | – | Sell |
-178,300
| Closed | -$6.59M | – | 3945 |
|
|
2022
Q4 | $6.59M | Buy |
+178,300
| New | +$6.59M | 0.01% | 1336 |
|
|
2022
Q2 | – | Sell |
-146,400
| Closed | -$1.88M | – | 4191 |
|
|
2022
Q1 | $1.88M | Buy |
+146,400
| New | +$1.88M | ﹤0.01% | 2275 |
|